{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:31:30Z","timestamp":1747204290497,"version":"3.40.5"},"posted":{"date-parts":[[2022,8,17]]},"group-title":"In Review","reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,8,11]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n Since the onset of the recent COVID-19 pandemic, there have been growing concerns regarding multisystem inflammatory syndrome in children (MIS-C). This study aims to describe the clinico-epidemiological profile and challenges in management of MIS-C in low-middle income countries by highlighting the Kenyan experience.\nMethods\n  A retrospective study at the Aga Khan University Hospital Nairobi, Avenue Hospital Kisumu and Kapsabet County Referral Hospital was undertaken to identify cases of MIS-C. A detailed chart review using the World Health Organization (WHO) data collection tool was adapted to incorporate information on socio-demographic details and treatment regimens.\nFindings:\n Twenty children with MIS-C were identified across the three facilities. Seventy percent of the children were male (14 of 20). COVID-19 PCR testing was done for five children and only one was positive. The commonest clinical symptoms were fever (90%), tachycardia (80%), prolonged capillary refill (80%), oral mucosal changes (65%) and peripheral cutaneous inflammation (50%). Four children required admission into the critical care unit for ventilation support and inotropic support. Cardiac evaluation was available for six patients four of whom had myocardial dysfunction, three had valvulitis and one had pericarditis. Immunoglobulin therapy was availed to two children and systemic steroids provided for three children. There were no documented mortalities.\nInterpretation:\n We describe the first case series of MIS-C in East and Central Africa. Majority of suspected cases of MIS-C did not have access to timely COVID-19 PCR testing and other appropriate evaluations which highlights the iniquity in access to diagnostics and treatment.<\/p>","DOI":"10.21203\/rs.3.rs-1951206\/v1","type":"posted-content","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T19:09:31Z","timestamp":1660763371000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Multisystem Inflammatory Syndrome in Children (MIS-C) in resource limited settings: The Kenyan Experience"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-7963","authenticated-orcid":false,"given":"ANGELA NYANGORE","family":"MIGOWA","sequence":"first","affiliation":[{"name":"Aga Khan University Medical College East Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Samia","sequence":"additional","affiliation":[{"name":"Aga Khan University Medical College East Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmit","family":"Shah","sequence":"additional","affiliation":[{"name":"Aga Khan University Medical College East Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean del","family":"Rossi","sequence":"additional","affiliation":[{"name":"Aga Khan University Medical College East Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chemutai","family":"Kenei","sequence":"additional","affiliation":[{"name":"University of Nairobi College of Health Sciences: University of Nairobi Faculty of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver Ombeva","family":"Malande","sequence":"additional","affiliation":[{"name":"Nakuru Provincial General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Ayaya","sequence":"additional","affiliation":[{"name":"Maseno University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy","family":"Jeruto","sequence":"additional","affiliation":[{"name":"Kabarak University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Oyiengo","sequence":"additional","affiliation":[{"name":"UNICEF Eastern and Southern Africa Regional Office"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Lewandowski","sequence":"additional","affiliation":[{"name":"NIAMS: National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"COVID-19 and Kawasaki Disease: Novel Virus and Novel Case","author":"Jones VG","year":"2020","unstructured":"Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J, et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr. 2020.","journal-title":"Hosp Pediatr"},{"key":"ref2","article-title":"COVID-19 in Children: Initial Characterization of the Pediatric Disease","author":"Cruz AT","year":"2020","unstructured":"Cruz AT, Zeichner SL. COVID-19 in Children: Initial Characterization of the Pediatric Disease. Pediatrics. 2020.","journal-title":"Pediatrics"},{"year":"2020","author":"Dong Y","key":"ref3","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020."},{"key":"ref4","article-title":"Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region","author":"DeBiasi RL","year":"2020","unstructured":"DeBiasi RL, Song X, Delaney M, Bell M, Smith K, Pershad J, et al. Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region. J Pediatr. 2020.","journal-title":"J Pediatr"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.048360","article-title":"Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic","author":"Belhadjer Z","year":"2020","unstructured":"Belhadjer Z, Meot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020.","journal-title":"Circulation"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11926-018-0711-y","article-title":"Vasculitis in Africa","volume":"20","author":"Genga E","year":"2018","unstructured":"Genga E, Oyoo O, Adebajo A. Vasculitis in Africa. Curr Rheumatol Rep. 2018;20(2):4.","journal-title":"Curr Rheumatol Rep"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-1711","article-title":"SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children","author":"Licciardi F","year":"2020","unstructured":"Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S, et al. SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children. Pediatrics. 2020.","journal-title":"Pediatrics"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1007\/s13312-020-1901-z","article-title":"Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab","author":"Balasubramanian S","year":"2020","unstructured":"Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab. Indian Pediatr. 2020.","journal-title":"Indian Pediatr"},{"key":"ref9","article-title":"Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series","author":"Chiotos K","year":"2020","unstructured":"Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, et al. Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series. J Pediatric Infect Dis Soc. 2020.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref10","first-page":"194599820930238","article-title":"Association Between COVID-19 and Kawasaki Disease: Vigilance Required From Otolaryngologists","author":"Sandhaus H","year":"2020","unstructured":"Sandhaus H, Crosby D, Sharma A, Gregory SR. Association Between COVID-19 and Kawasaki Disease: Vigilance Required From Otolaryngologists. Otolaryngol Head Neck Surg. 2020:194599820930238.","journal-title":"Otolaryngol Head Neck Surg"},{"year":"2020","author":"Schroeder AR","key":"ref11","unstructured":"Schroeder AR, Wilson KM, Ralston SL. COVID-19 and Kawasaki Disease: Finding the Signal in the Noise. Hosp Pediatr. 2020."},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","author":"Verdoni L","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020.","journal-title":"Lancet"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/S2352-4642(20)30272-8","article-title":"Multisystem inflammatory syndrome in children in South Africa","volume":"4","author":"Kate Webb DRA","year":"2020","unstructured":"Kate Webb DRA, Ayodele Faleye MM, Helena Rabie CS. Multisystem inflammatory syndrome in children in South Africa. Lancet Child Adolesc Health. 2020;4(10):e38.","journal-title":"Lancet Child Adolesc Health"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"ref15","volume-title":"Helena Rabie, Christiaan Scott, Liesl Z\u00fchlke, Kate Webb. The Clinical Features and Estimated Incidence of MIS-C in Cape Town, South Africa","author":"Claire Butters DRA","year":"2022","unstructured":"Claire Butters DRA, Stander R, Facey-Thomas H, Abrahams D, Faleye A, Allie N, Soni K. Helena Rabie, Christiaan Scott, Liesl Z\u00fchlke, Kate Webb. The Clinical Features and Estimated Incidence of MIS-C in Cape Town, South Africa. Research Square; 2022."},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19","volume":"325","author":"Feldstein LR","year":"2021","unstructured":"Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325(11):1074\u201387.","journal-title":"JAMA"},{"issue":"18","key":"ref17","first-page":"1794","article-title":"Multisystem Inflammatory Syndrome in Children in the United States. Reply","volume":"383","author":"Feldstein LR","year":"2020","unstructured":"Feldstein LR, Rose EB, Randolph AG. Multisystem Inflammatory Syndrome in Children in the United States. Reply. N Engl J Med. 2020;383(18):1794\u20135.","journal-title":"N Engl J Med"},{"key":"ref18","article-title":"Echocardiographic Findings and Correlation with Laboratory Values in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19","author":"Kavurt AV","year":"2021","unstructured":"Kavurt AV, Bagrul D, Gul AEK, Ozdemiroglu N, Ece I, Cetin II, et al. Echocardiographic Findings and Correlation with Laboratory Values in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19. Pediatr Cardiol. 2021.","journal-title":"Pediatr Cardiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e023251","DOI":"10.1161\/JAHA.121.023251","article-title":"Longitudinal Assessment of Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children Associated With COVID-19 Infections","author":"Matsubara D","year":"2022","unstructured":"Matsubara D, Chang J, Kauffman HL, Wang Y, Nadaraj S, Patel C, et al. Longitudinal Assessment of Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children Associated With COVID-19 Infections. J Am Heart Assoc. 2022:e023251.","journal-title":"J Am Heart Assoc"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-1951206\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-1951206\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T19:09:46Z","timestamp":1660763386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-1951206\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":19,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-1951206\/v1","relation":{},"subject":[],"published":{"date-parts":[[2022,8,17]]},"subtype":"preprint"}}